BissadaN. K., FinkbeinerA. E., WelchL. T.: Lower urinary tract pharmacology, anatomic considerations. Urology, 9; 107 (1977).
3.
BissadaN. K., FinkbeinerA. E., WelchL. T.: Lower urinary tract pharmacology, neuropharmacologic basis for lower urinary tract dynamics. Urology, 9; 357 (1977).
4.
BorsE., ComarrA. E.: The effect of pharmacologic agents. In: Neurological Urology, p. 210. S. KargerNew York1971.
5.
BoyarskyS., LabayP., HanickP., AbramsonA. S., BoyarskyR.: Care of the patient with neurogenic bladder. Little Brown & Co., Boston1979.
6.
BradleyW. E.: Relazione al Congresso di Bologna della Soc. Ital. Urol., 1977.
7.
BrindleyG. S., PolkeyC. E., RushtonD. N.: Sacral anterior root stimulators for bladder control in paraplegia. Paraplegia, 20; 365 (1982).
8.
ButtarazziP. J.: Oxybutynin chloride (Ditropan) in enuresis. J. Urol., 118; 46 (1977).
9.
DesertJ. F., MauryM.: Séquelles neurovegetatives et reéducation vésico-sphinctérienne. In: Medicine de Reéducation, p. 309. Ed. Flammarion Medicale, 1981.
10.
DioknoA. C.: LapidesJ.: Oxybutynin: a new drug with analgesic and anticholinergic properties. J. Urol., 108; 307 (1972).
11.
Di BenedettoP., SorbilliG., CilentoF., MarcoliniE., SoldatiR.: I disturbi vo scico-sfinterici nelle lesioni midollari traumatiche: moderne acquisizioni diagnostico-terapeutiche. Atti Congr. SIMFER1979.
12.
FinkbeinerA. E., BissadaN. K., WelchL.: Uropharmacology: IV. Parasympathomimetic drugs. Urology, 9; 474 (1977).
13.
AndersonG. F., FredericksC. M.: Characterization of the oxybutynin antagonism of drug-induced spasm in detrusor. Pharmacology, 15; 31 (1977).
14.
GiacobiniS., CrucianiE., FagioliA., CerniliC., TenagliaR., GallucciM., GueraniA.: Studio comparativo tra prifinio bromuro (Riabal) e cloruro di ossibutinina (Ditropan) nella terapia della instabilità vescicale. Urologia, 48; 535 (1981).
15.
FredericksC. M., AndersonG. F., KreulenD. L.: Study of the anticholinergic and antispasmodic activity of oxybutynin (Ditropan) on rabbit detrusor. Invest. Urol., 12; 317 (1975).
16.
GuttmanL.: Spinal Cord Injuries, p. 345. Blachwell Scientific Pubblications, Oxford1976.
17.
BrooksM. E., BrafZ. F.: Oxybutynin chloride (Ditropan). Clinical uses and limitations. Paraplegia, 18; 64 (1980).
18.
HachenH. J.: La vescica neurologica dell'adulto: tecnica di esplorazione e metodi di trattamento. Urodynamics Symposia1980.
19.
HilwaN., PerlmutterA. D.: The role of adjunctive drug therapy for intermittent catheterization and self-catheterization in children with vesical dysfunction. J. Urol., 119; 551 (1978).
KraneR. J., SirokyM. B.: Clinical Neuro-Urology, pag. 143. Little Brown & Co., Boston1979.
22.
LishP. M., LabuddeJ. A., PetersE. L., RobbinsS. I.: Oxybutynin. A musculotropic antispasmodic drug with moderate anticholinergic action. Arch. Intern. Pharmacodyn., 156; 467 (1965).
23.
MinaireP.: Paraplégie et tétraplégie, pag. 167. Masson éd., Paris1979.
24.
MoiseyC. U., StephensonT. P., BrendlerC. B.: The urodynamic and subjective results of treatment of detrusor instability with Oxybutynin chloride. Brit. J. Urol., 52; 472 (1980).
25.
MulcahyJ. J., JamesH. E., McRobertsJ. W.: Oxybutynin chloride combined with clean catheterization in the treatment of myelomeningocele patients. J. Urol., 113; 95 (1977).
26.
O'ShaughnessyE. J., ClowersD. E., BrooksG.: Detrusor reflex contraction inhibited by anal strech. Arch. Phys. Med. Rehabil., 62; 128 (1981).
27.
PansadoroV., PuloneM.: Il cloruro di ossibutinina nella terapia della vescica iperreflessica e dell'«urge incontinence». Urologia, 46; 729 (1979).
28.
PaulsonD. F.: Oxybutynin chloride in control of post-transurethral vesical pain and spasm. Urology, 11; 237 (1978).
29.
RadaelliE., ZanolloA.: Principi fondamentali nello studio della vescica neurologica; cenni di profilassi delle complicanze e indirizzi terapeutici. Riabilitazione, 2; 70 (1969).
30.
SorbilliG., Di BenedettoP., SoldatiR.: La nostra esperienza nella rieducazione della vescica neurologica nel paraplegico post-traumatico. Eur. Medicophysica, 14; 149 (1978).
JurascheckF., WalkerJ. C., PerrigotM.: Tableau synoptique des drogues utilisables au niveau de l'appareil vésico-sphincterien. In: La Paraplégie di M. Maury, pag. 305. Ed. Flammarion, Paris1981.